Cargando…

Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation

SUMMARY: The aim was to meta-analyze randomized controlled trials of calcium plus vitamin D supplementation and fracture prevention. Meta-analysis showed a significant 15 % reduced risk of total fractures (summary relative risk estimate [SRRE], 0.85; 95 % confidence interval [CI], 0.73–0.98) and a 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weaver, C. M., Alexander, D. D., Boushey, C. J., Dawson-Hughes, B., Lappe, J. M., LeBoff, M. S., Liu, S., Looker, A. C., Wallace, T. C., Wang, D. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715837/ https://www.ncbi.nlm.nih.gov/pubmed/26510847 http://dx.doi.org/10.1007/s00198-015-3386-5

Ejemplares similares

Re: Errors in the NOF meta-analysis of calcium and vitamin D supplements
por: Weaver, C. M., et al.
Publicado: (2016)

Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation
por: Shams-White, Marissa M., et al.
Publicado: (2018)

Osteoanabolic Agents for Osteoporosis
por: Haas, Andrea V, et al.
Publicado: (2018)

The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations
por: Weaver, C. M., et al.
Publicado: (2016)

Erratum to: The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations
por: Weaver, C. M., et al.
Publicado: (2016)

Clinician’s Guide to Prevention and Treatment of Osteoporosis
por: Cosman, F., et al.
Publicado: (2014)

Erratum to: Clinician’s guide to prevention and treatment of osteoporosis
por: Cosman, F., et al.
Publicado: (2015)

The clinician’s guide to prevention and treatment of osteoporosis
por: LeBoff, M. S., et al.
Publicado: (2022)

Correction to: The clinician’s guide to prevention and treatment of osteoporosis
por: LeBoff, M. S., et al.
Publicado: (2022)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
por: Watts, N.B., et al.
Publicado: (2020)

Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis
por: Touskova, Tereza, et al.
Publicado: (2015)

VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population
por: LeBoff, Meryl S, et al.
Publicado: (2020)

A Randomized Trial of Vitamin D(3) Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption
por: Lewis, R. D., et al.
Publicado: (2013)

Effects of Vitamin D(3) Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)
por: Chou, Sharon H, et al.
Publicado: (2021)

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis
por: Songpatanasilp, T., et al.
Publicado: (2016)

Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA‐3 TriaL (VITAL)
por: LeBoff, Meryl S, et al.
Publicado: (2020)

Why randomized controlled trials of calcium and vitamin D sometimes fail
por: Lappe, Joan M., et al.
Publicado: (2012)

The use of calcium and vitamin D in the management of osteoporosis
por: Sunyecz, John A
Publicado: (2008)

Effect of vitamin D on serum markers of bone turnover in SLE in a randomised controlled trial
por: Tedeschi, Sara K., et al.
Publicado: (2019)

Association of Body Weight With Response to Vitamin D Supplementation and Metabolism
por: Tobias, Deirdre K., et al.
Publicado: (2023)

Cost-benefit analysis of calcium and vitamin D supplements
por: Weaver, Connie M., et al.
Publicado: (2019)

Patient preference and acceptability of calcium plus vitamin D(3) supplementation: a randomised, open, cross-over trial
por: den Uyl, Debby, et al.
Publicado: (2009)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
por: Body, J.-J., et al.
Publicado: (2012)

Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?
por: Barnard, Karen, et al.
Publicado: (2016)

Effects of Vitamin D Plus Calcium Supplements on Pharmacokinetics of Isoflavones in Thai Postmenopausal Women
por: Teekachunhatean, Supanimit, et al.
Publicado: (2011)

Editorial: Plant Foods and Dietary Supplements: Building Solid Foundations for Clinical Trials
por: Sorkin, Barbara C., et al.
Publicado: (2022)

Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand
por: Songpatanasilp, Thawee, et al.
Publicado: (2018)

Dietary Calcium Intake and Calcium Supplementation in Hungarian Patients with Osteoporosis
por: Speer, Gábor, et al.
Publicado: (2013)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

Validation of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-31) in Chinese
por: Lai, Billy M. H., et al.
Publicado: (2010)

Implementation of Calcium and Vitamin D Supplementation in Glucocorticosteroid-Induced Osteoporosis Prevention Guidelines—Insights from Rheumatologists
por: Gazitt, Tal, et al.
Publicado: (2023)

COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey
por: Singer, A.J., et al.
Publicado: (2021)

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis
por: Sakai, A., et al.
Publicado: (2015)

Effect of Vitamin D(3) and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial
por: Orkaby, Ariela R., et al.
Publicado: (2022)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan, Tao, et al.
Publicado: (2013)

Erratum to: Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis
por: Sakai, A., et al.
Publicado: (2015)

OA02.01. Effect of macronutrient composition of weight loss diets on reduction of the inflammatory marker hsCRP
por: Nicklas, J, et al.
Publicado: (2012)

640. Prospective Association of Serum Vitamin D Level with Sepsis-Mortality in Postmenopausal Women: Results From the Women’s Health Initiative
por: Pinargote, Paulette, et al.
Publicado: (2018)

Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
por: Nakamura, Yukio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v8dk99jvm3i43ohcvsk330d45f